Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Arthritis and Rheumatism
|
July 1, 2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry
F Tubach, D Salmon, P Ravaud, et al.
Gastroenterologie Clinique Et Biologique
|
February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]
A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Alimentary Pharmacology & Therapeutics
|
January 3, 2013
Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease
P B Allen, M A Kamm, L Peyrin-Biroulet, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Arthritis and Rheumatism
|
July 1, 2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry
F Tubach, D Salmon, P Ravaud, et al.
Gastroenterologie Clinique Et Biologique
|
February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]
A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Alimentary Pharmacology & Therapeutics
|
January 3, 2013
Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease
P B Allen, M A Kamm, L Peyrin-Biroulet, et al.
Page
of 5